Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites
Biology Open · 15.04.2023 · 12 (4)
DOI: 10.1242/bio.059707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, online erschienen am 03.04.2023. Verfasst von Lara Cantarero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, 08950, Barcelona, Spain. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Intracellular Membranes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Barcelona: Universitat de Barcelona.
Abstract (Originalsprache)
GDAP1 pathogenic variants cause Charcot-Marie-Tooth (CMT) disease, the most common hereditary motor and sensory neuropathy. CMT-GDAP1 can be axonal or demyelinating, with autosomal dominant or recessive inheritance, leading to phenotypic heterogeneity. Recessive GDAP1 variants cause a severe phenotype, whereas dominant variants are associated with a milder disease course. GDAP1 is an outer mitochondrial membrane protein involved in mitochondrial membrane contact sites (MCSs) with the plasmatic membrane, the endoplasmic reticulum (ER), and lysosomes. In GDAP1-deficient models, the pathophysiology includes morphological defects in mitochondrial network and ER, impaired Ca2+ homeostasis, oxidative stress, and mitochondrial MCSs defects. Nevertheless, the underlying pathophysiology of dominant variants is less understood. Here, we study the effect upon mitochondria–lysosome MCSs of two GDAP1 clinical variants located in the α-loop interaction domain of the protein. p.Thr157Pro dominant variant causes the increase in these MCSs that correlates with a hyper-fissioned mitochondrial network. In contrast, p.Arg161His recessive variant, which is predicted to significantly change the contact surface of GDAP1, causes decreased contacts with more elongated mitochondria. Given that mitochondria–lysosome MCSs regulate Ca2+ transfer from the lysosome to mitochondria, our results support that GDAP1 clinical variants have different consequences for Ca2+ handling and that could be primary insults determining differences in severity between dominant and recessive forms of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, 08950, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, 08950, Barcelona, Spain.
- Department of Genetic Medicine - IPER, Hospital Sant Joan de Déu, 08950, Barcelona, Spain.
- Division of Pediatrics, Faculty of Medicine and Health Sciences, University of Barcelona, 08036, Barcelona, Spain.
- ERN-ITHACA.
ORCID-Profile: Lara Cantarero, Gisela García-Vargas, Janet Hoenicka, Francesc Palau
Förderung
- University of Barcelona: Universitat de Barcelona
Zitieren
APA
Cantarero, L., García-Vargas, G., Hoenicka, J., & Palau, F. (2023). Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites. Biology Open, 12(4). https://doi.org/10.1242/bio.059707
Vancouver
Cantarero L, García-Vargas G, Hoenicka J, Palau F. Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites. Biology Open. 2023;12(4). doi:10.1242/bio.059707
BibTeX
@article{Cantarero2023,
author = {Cantarero, Lara and García-Vargas, Gisela and Hoenicka, Janet and Palau, Francesc},
title = {Differential effects of Mendelian GDAP1 clinical variants on mitochondria-lysosome membrane contacts sites},
journal = {Biology Open},
year = {2023},
volume = {12},
number = {4},
doi = {10.1242/bio.059707}
}
EUVIMED